ArticleJournal of vitreoretinal diseases

High-Dose Aflibercept for Neovascular AMD and DME in Suboptimal Responders to Standard-Dose Aflibercept.

Jared S Nielsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.